FAM
PBYI icon

Fred Alger Management’s Puma Biotechnology PBYI Stock Holding History

Fred Alger Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,470,965
Closed -$17.3M – 546
2021
Q3 		$17.3M Sell
2,470,965
-515,011
-17% -$3.86M 0.04% 207
2021
Q2 		$27.4M Sell
2,985,976
-640,661
-18% -$6.49M 0.06% 193
2021
Q1 		$35.3M Buy
3,626,637
+210,634
+6% +$2.35M 0.09% 180
2020
Q4 		$35M Buy
3,416,003
+83,480
+3% +$845K 0.09% 167
2020
Q3 		$33.6M Buy
3,332,523
+858,494
+35% +$8.74M 0.1% 146
2020
Q2 		$25.8M Buy
2,474,029
+139,062
+6% +$1.44M 0.09% 149
2020
Q1 		$19.7M Buy
2,334,967
+563,782
+32% +$5.48M 0.09% 151
2019
Q4 		$15.5M Buy
1,771,185
+104,506
+6% +$865K 0.06% 180
2019
Q3 		$17.9M Buy
1,666,679
+479,743
+40% +$5.18M 0.07% 166
2019
Q2 		$15.1M Sell
1,186,936
-3,739
-0.3% -$86.1K 0.06% 171
2019
Q1 		$46.2M Buy
1,190,675
+368,634
+45% +$11.3M 0.18% 119
2018
Q4 		$16.7M Sell
822,041
-79,141
-9% -$2.38M 0.08% 157
2018
Q3 		$41.3M Buy
901,182
+516,344
+134% +$24.9M 0.16% 126
2018
Q2 		$22.8M Buy
384,838
+125,815
+49% +$7.29M 0.1% 147
2018
Q1 		$17.6M Buy
259,023
+68,088
+36% +$5.1M 0.08% 155
2017
Q4 		$18.9M Buy
190,935
+3,817
+2% +$427K 0.09% 144
2017
Q3 		$22.4M Sell
187,118
-20,766
-10% -$1.93M 0.1% 132
2017
Q2 		$18.2M Sell
207,884
-89,530
-30% -$5.01M 0.09% 144
2017
Q1 		$11.1M Buy
+297,414
New +$10.9M 0.06% 166
2015
Q2 		– Sell
-94,166
Closed -$22.2M – 527
2015
Q1 		$22.2M Sell
94,166
-112,532
-54% -$24.1M 0.1% 148
2014
Q4 		$39.1M Buy
206,698
+44,794
+28% +$9.94M 0.19% 110
2014
Q3 		$38.6M Sell
161,904
-61,386
-27% -$12.6M 0.19% 108
2014
Q2 		$14.7M Buy
223,290
+80,733
+57% +$5.74M 0.07% 216
2014
Q1 		$14.8M Buy
142,557
+21,481
+18% +$2.52M 0.07% 250
2013
Q4 		$12.5M Buy
121,076
+119,746
+9,003% +$7.03M 0.06% 275
2013
Q3 		$71K Buy
+1,330
New +$71.7K ﹤0.01% 462

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fred Alger Management's PBYI Position: Q4 2021 in Review

Fred Alger Management sold out of Puma Biotechnology (PBYI) in Q4 2021, closing a stake of 2,470,965 shares — an estimated $17.3M sold.

Fred Alger Management first reported a position in PBYI in Q3 2013 and held it in 26 quarters. The position peaked at $46.2M in Q1 2019. 102 funds tracked by Wall St. Rank hold PBYI as of Q4 2021.

  • Fred Alger Management reported no remaining Puma Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Fred Alger Management sold 2,470,965 Puma Biotechnology shares in Q4 2021, an estimated $17.3M.
  • Fred Alger Management first reported a position in Puma Biotechnology in Q3 2013 and held it in 26 quarters.
  • Fred Alger Management's Puma Biotechnology position peaked at $46.2M in Q1 2019.
  • 102 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2021.

Based on Fred Alger Management's 13F filing for Q4 2021, filed 14 Feb 2022.